imipenem, anhydrous has been researched along with Bacteremia in 173 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.58) | 18.7374 |
| 1990's | 37 (21.39) | 18.2507 |
| 2000's | 55 (31.79) | 29.6817 |
| 2010's | 70 (40.46) | 24.3611 |
| 2020's | 10 (5.78) | 2.80 |
| Authors | Studies |
|---|---|
| Cauda, R; Citton, R; D'Inzeo, T; Fadda, G; Fiori, B; Montuori, E; Posteraro, B; Sanguinetti, M; Spanu, T; Trecarichi, EM; Tumbarello, M | 1 |
| Avlami, A; Daikos, GL; Katsilambros, N; Kosmidis, C; Petrikkos, G; Psychogiou, M; Stefanou, I; Tassios, PT; Vasilakopoulou, A | 1 |
| Bajolet, O; Berthelot, P; Bingen, E; Couetdic, G; Favre, R; Grattard, F; Hocquet, D; Husson, MO; Jeannot, K; Mariani-Kurkdjian, P; Marty, N; Plésiat, P; Roussel-Delvallez, M | 1 |
| Hawley, JS; Jorgensen, JH; Murray, CK | 1 |
| Cauda, R; D'Inzeo, T; De Pascale, G; Fadda, G; Fiori, B; Leone, F; Rossi, M; Sali, M; Sanguinetti, M; Spanu, T; Trecarichi, EM; Tumbarello, M | 1 |
| Goering, RV; Hanson, ND; Kurpiel, PM; Palepou, MF; Wolter, DJ; Woodford, N | 1 |
| Chung, DR; Ko, KS; Peck, KR; Son, JS; Song, JH; Suh, JY | 1 |
| Chien, CC; Lee, CH; Li, CC; Liu, JW; Su, LH; Tang, YF | 1 |
| Chen, Y; Luo, Q; Qiu, Y; Shen, P; Xiao, Y; Xu, H; Yu, W | 1 |
| Hou, JY; Huang, HM; Huang, TH; Liu, HC; Lu, CH; Sun, FJ; Yeh, TC | 1 |
| Chang, H; Liu, CP; Sun, FJ; Wang, NY; Wu, AY | 1 |
| Han, J; Jeong, HT; Kim, HG; Song, JE | 1 |
| Hu, X; Huang, H; Li, W; Zhang, D; Zhang, X | 1 |
| Funayama, Y; Hitomi, S; Ishikawa, H; Kiyasu, Y; Saito, K | 1 |
| Huang, C | 1 |
| Guo, Q; Guo, S | 1 |
| Chen, TL; Huang, TW; Kuo, SC; Lee, YT; Lin, PY; Liu, CP; Liu, IF; Liu, YM; Wang, FD; Wang, YC; Yang, YS | 1 |
| Cai, J; Cui, W; Huang, J; Qian, Z; Song, F; Zhang, G; Zhang, K; Zheng, C; Zhou, F; Zhou, H | 1 |
| Chen, CH; Lin, CH; Lin, JS | 1 |
| Gemperli, R; Gomez, DS; Levin, AS; Machado, AS; Oliveira, MS; Sanches, C; Santos, SRCJ; Silva Junior, CVD | 1 |
| Cahan, A; Cohen, MJ; Kleinhendler, E; Moses, AE; Paltiel, O; Strahilevitz, J | 1 |
| Chen, CL; Chiu, CH; Hsu, JF; Hsu, SY; Lee, HY; Wang, YH | 1 |
| Almela, M; Cruceta, A; de Alarcón, A; Del Río, A; Eworo, A; García-de-la-Mària, C; Marco, F; Mestres, CA; Miró, JM; Moreno, A; Muñoz, P; Paré, JC; Peña, C; Pericàs, JM | 1 |
| Advincula, MR; McLaughlin, MM; Miglis, C; Scheetz, MH; Skoglund, E; Wagner, J | 1 |
| Cha, MK; Chung, DR; Kang, CI; Kim, SH; Lee, NY; Peck, KR; Song, JH | 1 |
| Hsueh, PR; Hsueh, SC; Huang, YT; Lee, YJ; Liao, CH; Tsuji, M | 1 |
| Jeverica, S; Nagy, E; Papst, L; Premru, MM; Sóki, J | 1 |
| Horner, C; Livermore, DM; Mushtaq, S | 1 |
| Callan, K; Canver, MC; Chen, L; Fauntleroy, K; Jenkins, SG; Kreiswirth, BN; La Spina, M; Robertson, A; Satlin, MJ; Westblade, LF | 1 |
| Kaniga, K; Lee, M; Redman, R; Rice, DA | 1 |
| Deris, ZZ; Harun, A; Shafei, MN | 1 |
| Chen, TL; Dou, HY; Fung, CP; Huang, L; Kuo, SC; Lee, MH; Lee, YT; Yu, KW | 1 |
| Amores Arriaga, MB; Bucar Barjud, M; Gómez del Valle, C; Josa Laorden, C; Pérez Calvo, JI; Torralba Cabeza, MA | 1 |
| Bourdier, A; Haouy, S; Marchandin, H; Michon, AL; Saumet, L; Sirvent, N | 1 |
| Chen, W; Harris, G; Kanzaki, G; Kuo Lee, R; Lam, CK; Patel, GB; Xu, HH | 1 |
| Calcaño, C; Fuenmayor, Z; Montaño, C; Piñerúa Gonsálvez, JF; Rodney, H; Rodney, M; Zambrano Infantinot, Rdel C | 1 |
| Bolac, C; Brassat, S; Camus, M; Cante, V; Guillet, G; Paquier-Valette, C | 1 |
| Biçmen, M; Gülay, Z; Sarı, AN | 1 |
| Chen, CL; Chiu, CH; Huang, CW; Lee, HY; Wu, SR | 1 |
| Najar Peerayeh, S; Pakbaten Toupkanlou, S; Pirhajati Mahabadi, R; Siadat, SD | 1 |
| Hayakawa, K; Kirikae, T; Kubota, S; Kuroda, E; Kutsuna, S; Mezaki, K; Miyoshi-Akiyama, T; Nagamatsu, M; Ohmagari, N; Shimada, K; Sugiki, Y; Takeshita, N; Tojo, M | 1 |
| Bonomo, RA; Spellberg, B | 1 |
| Carratalà, J; Cuquet, J; del Río, A; Garcia de la Mària, C; Gasch, O; Gatell, JM; Gudiol, F; Marco, F; Mestres, CA; Miró, JM; Moreno, A; Pare, JC; Peña, C; Soy, D; Suárez, C; Tubau, F | 1 |
| Chao, CM; Hsu, HY | 1 |
| Chiu, CH; Lee, HY | 1 |
| Bustorff, M; Pereira, L; Pestana, M; Sampaio, S; Tavares, I | 1 |
| Jaruratanasirikul, S; Jullangkoon, M; Samaeng, M; Wongpoowarak, W | 1 |
| Chang, CJ; Chen, CL; Chiu, CH; Huang, CW; Lee, HY; Wang, YH | 1 |
| Chia, JH; Hsu, PC; Kuo, AJ; Lee, CH; Lee, MH; Su, TY; Ye, JJ | 1 |
| Gentry, CA; Williams, RJ | 1 |
| Bai, KJ; Hsieh, TC; Hsu, CW; Jean, SS; Lam, C; Lee, WS | 1 |
| Altboum, Z; Bar-David, E; Glinert, I; Kobiler, D; Levy, H; Schlomovitz, J; Sittner, A; Weiss, S | 1 |
| Chen, TL; Chiu, CH; Fung, CP; Kuo, SC; Lee, YT; Lin, JC; Wang, FD; Wang, YC; Yang, YS; Yin, T | 1 |
| Jeon, H; Kang, HY; Kim, BR; Kim, CH; Lee, JC; Lee, SH; Lee, YC | 1 |
| Calfee, DP; Eiras, DP; Furuya, EY; Gomez-Simmonds, A; Jenkins, SG; Kubin, CJ; Loo, A; Nelson, B; Satlin, MJ; Whittier, S | 1 |
| Chen, SS; Hsueh, PR; Hung, KH; Kao, CY; Wu, HM; Wu, JJ; Yan, JJ | 1 |
| Aracil-García, B; Campos, J; Cuevas-Lobato, Ó; Fernández-Romero, S; Lara-Fuella, N; Oteo-Iglesias, J; Pérez-Grajera, I; Pérez-Vázquez, M | 1 |
| Isome, K; Iwata, A; Matsubara, K; Nigami, H; Tasaka, K; Yamamoto, G | 1 |
| Barba, MJ; Bou, G; Kostrzewa, M; Oviaño, M; Sparbier, K | 1 |
| Saito, H; Starr, ME; Steele, AM | 1 |
| Adukauskiene, D; Dambrauskiene, A; Jeroch, J; Vitkauskiene, A | 1 |
| Batlle, M; de la Cámara, R; de la Rubia, J; Debén, G; Díaz, J; García, R; Jarque, I; Juliá, A; Lahuerta, JJ; López, J; Martino, R; Montesinos, P; Rovira, M; Sanz, MA; Vázquez, L | 1 |
| Ariza, J; Dominguez, MA; Gavaldà, L; Gudiol, F; Manzur, A; Peña, C; Pujol, M; Suárez, C; Tubau, F | 1 |
| Chan, YY; Deris, ZZ; Habsah, H; Noraida, R; Ravichandran, M; Rosliza, AR; Tan, GC; Van Rostenberghe, H | 1 |
| Aydemir, ZA; Celik, N; Celkan, T; Ozdemir, N | 1 |
| Cavallo, JD; Chomarat, M; Dubreuil, L; Joly-Guillou, ML; Kempf, M; Maugein, J; Muller-Serieys, C; Roussel-Delvallez, M | 1 |
| Del Gaudio, T; Miragliotta, G; Mosca, A | 1 |
| Dizbay, M; Hizel, K; Sezer, BE; Tunccan, OG | 1 |
| Harris, AD; Hsiao, WW; Johnson, JK; Rasko, DA; Stine, OC; Thom, KA | 1 |
| Ariza, J; Cabellos, C; Domínguez, MA; Fernández, R; Gudiol, F; Pachón-Ibáñez, ME; Ribes, S; Tubau, F | 2 |
| Deris, ZZ; Hasan, H; Siti Suraiya, MN | 1 |
| Ko, KS; Lee, H; Peck, KR; Song, JH | 1 |
| Dambrauskienė, A; Macas, A; Sakalauskas, R; Skrodenienė, E; Vitkauskienė, A | 1 |
| Altboum, Z; Kobiler, D; Levy, H; Ophir, Y; Pass, A; Rothschild, N; Schlomovitz, J; Tal, A; Weiss, S | 1 |
| Hsueh, PR; Huang, WH; Ko, WC; Lee, NY; Tsui, KC | 1 |
| Bert, F; Fantin, B; Gellen-Dautremer, J; Lefort, A; Panhard, X | 1 |
| Akalın, H; Akova, M; Arman, D; Aygen, B; Başaran, S; Bayramoğlu, G; Dizbay, M; Dokuzoğuz, B; Eraksoy, H; Esener, H; Hasçelik, G; Köksal, I; Korten, V; Oğünç, D; Sınırtaş, M; Söyletir, G; Sümerkan, B; Tünger, A; Ulusoy, S; Yalçın, AN | 1 |
| Choi, JY; Jung, SI; Kim, DH; Kim, SH; Ko, KS; Park, KH; Park, YK | 1 |
| Goto, H; Higaki, M; Honda, K; Ishii, H; Mikura, S; Nakamura, M; Okazaki, M; Tsunoda, T; Wada, H; Watanabe, T; Yasutake, T | 1 |
| Jung, SI; Kim, SH; Ko, KS; Park, KH; Park, YK | 1 |
| Cho, YK; Choi, JY; Kang, CI; Kim, HS; Kim, MJ; Ko, KS; Lee, HJ; Lee, MS; Park, DW; Peck, KR | 1 |
| Chang, SC; Chen, WC; Chen, YC; Hu, FC; Wang, JL; Wu, UI; Yang, CS | 1 |
| Maherault, AC; Nordmann, P; Pangon, B; Therby, A | 1 |
| Abubakar, S; Chin, E; Halim, HA; Hanifah, YA; Jaafar, FL; Karunakaran, R; Ng, KP | 1 |
| Decker-Burgard, S; Laeuffer, J; Morrissey, I; Mutters, R; Seifert, H; Valenza, G | 1 |
| Hsueh, PR; Huang, WH; Ko, WC; Lee, CC; Lee, NY; Tsui, KC | 1 |
| Choi, EH; Hong, KB; Kang, DK; Kim, EC; Lee, HJ; Lim, JH; Oh, HS; Park, JD; Son, IS; Song, JS | 1 |
| Ko, KS; Lee, JY | 1 |
| Chang, SC; Dong, SX; Wang, JT | 1 |
| Arpin, C; Bezian, MC; Dubois, V; Gachie, JP; Gavinet, AM; Maire, JP; Menard, F; Quentin, C; Rogues, AM | 1 |
| Casanova, JL; de Boer, T; Dupuis, S; Koscielniak, E; Naumann, L; Ottenhoff, TH | 1 |
| Amicosante, G; Colì, A; Endimiani, A; Lombardi, G; Luzzaro, F; Perilli, M; Tamborini, A; Toniolo, A | 1 |
| Doerschug, KC; Hunninghake, GW; Monick, MM; Powers, LS; Thorne, PS | 1 |
| Aoki, S; Gotoh, N; Hirakata, Y; Kamihira, S; Kohno, S; Kondoh, A; Miyazaki, Y; Tomono, K; Yamada, Y; Yanagihara, K | 1 |
| Bonomo, RA; Casellas, JM; Goossens, H; Klugman, KP; Ko, WC; McCormack, JG; Mohapatra, S; Mulazimoglu, L; Paterson, DL; Rice, LB; Trenholme, G; Von Gottberg, A; Wagener, MM; Yu, VL | 1 |
| Bal, C; Bauernfeind, A; Ersöz, G; Otağ, F; Salcioğlu, M; Schneider, I | 1 |
| Balaban, N; Cirioni, O; D'Amato, G; Del Prete, MS; Dell'Acqua, G; Ghiselli, R; Giacometti, A; Mocchegiani, F; Orlando, F; Rocchi, M; Saba, V; Scalise, G; Silvestri, C | 1 |
| Gales, AC; Reis, AO; Sader, HS; Silbert, S | 1 |
| Chryssouli, Z; Galani, I; Giamarellou, H; Orlandou, K; Souli, M | 1 |
| Choe, KW; Kang, CI; Kim, EC; Kim, HB; Kim, SH; Lee, KD; Oh, MD; Park, WB | 1 |
| Castagnola, E; Caviglia, I; Giona, F; Girmenia, C; Haupt, R; Micozzi, A; Parodi, S; Testi, AM | 1 |
| Guo, SM; Hsueh, PR; Jean, SS; Lee, YT | 1 |
| Bar, K; Bearman, GM; Edmond, MB; Marra, AR; Wenzel, RP | 1 |
| Anagnostopoulos, A; Fassas, A; Hadjikyrkou, M; Kontodimou, A; Papageorgiou, T; Proya, E | 1 |
| Alvarez-Lerma, F; Castillo, F; Cerdá, E; Insausti, J; Martínez-Pellús, A; Olaechea, P; Palomar, M | 1 |
| Balaban, N; Cirioni, O; Dell'Acqua, G; Ghiselli, R; Giacometti, A; Licci, A; Mocchegiani, F; Orlando, F; Saba, V; Scalise, G; Silvestri, C | 1 |
| Ding, L; Gong, J; Hu, B; Hu, J; Li, QQ; Liu, S; Reed, E; Sun, Z; Wang, J; Xu, M; Yan, Q; Zhu, X | 1 |
| Bethimouti, K; Ikonomidis, A; Kondyli, L; Legakis, NJ; Maniatis, AN; Markogiannakis, A; Pournaras, S; Tsakris, A | 1 |
| Choi, JY; Kim, CO; Kim, JM; Kim, MS; Kim, YA; Kim, YK; Lee, K; Park, YS; Shin, SY; Song, YG; Yong, D; Yoon, HJ | 1 |
| Choe, KW; Kang, CI; Kim, DM; Kim, EC; Kim, HB; Kim, NJ; Lee, CS; Oh, MD | 1 |
| Luczak, M; Marchel, H; Rudnicka, J; Wroblewska, MM | 1 |
| Daikos, GL; Ganteris, G; Malamou-Lada, E; Petropoulou, D; Syriopoulou, VP; Tzanetou, K | 1 |
| Chien, CC; Kuo, CY; Liu, JW; Tsai, MS; Wang, MC; Wu, HC | 1 |
| Archontoulis, N; Giamarellos-Bourboulis, EJ; Giamarellou, H; Mega, A; Pavleas, I; Rigas, K; Thomopoulos, G; Vernikos, P | 1 |
| Chang, HH; Heo, ST; Jung, DS; Jung, SI; Kim, SW; Ko, KS; Kwon, KT; Lee, NY; Oh, WS; Peck, KR; Rhee, JY; Ryu, SY; Shin, SY; Song, JH | 1 |
| Avlami, A; Daikos, GL; Gargalianos, P; Karabinis, A; Kosmidis, C; Malamou-Lada, H; Paramythiotou, E; Petropoulou, D; Syriopoulou, VP; Tzanetou, K | 1 |
| Bonnaure-Mallet, M; Jolivet-Gougeon, A; Sixou, JL; Tamanai-Shacoori, Z | 1 |
| Antón-Aranda, E; Martí Cabané, J | 1 |
| Enoh, VT; Lin, CY; Lin, SH; Murphey, ED; Sherwood, ER; Toliver-Kinsky, T; Varma, TK | 1 |
| Melzer, M; Petersen, I | 1 |
| Coelho, F; da Cunha, S; Marques, N; Meliço-Silvestre, A; Sá, R | 1 |
| Chang, CM; Chuang, YC; Ko, WC; Lee, HC; Lee, NY; Wang, CL; Wang, LR; Yu, WL | 1 |
| Bourra, B; Brun-Buisson, C; Gazaigne, L; Legrand, P; Lesprit, P; Renaud, B; Taillandier, E | 1 |
| Laoprasopwattana, K; Laosombat, V; Pruekprasert, P; Wongchanchailert, M | 1 |
| Actis, LA; Cisneros, JM; Fernández-Cuenca, F; Martí, S; Martínez-Martínez, L; McQueary, C; Pachón, J; Pascual, A; Rodríguez-Baño, J; Soto, S; Vila, J | 1 |
| Demircioğlu, F; Oren, H | 1 |
| Bucklin, SE; Lake, P; Lögdberg, L; Morrison, DC | 1 |
| Kuijper, EJ; Prins, JM; Speelman, P; van Agtmael, MA; van Deventer, SJ | 1 |
| Delia, S; Iona, E; Mascellino, MT; Mastroianni, CM; Ponzo, R | 1 |
| Lacey, SL; Want, SV | 1 |
| Edwards, R; Gazis, A; Greenwood, D; Ispahani, P; Turner, P; Weston, V | 1 |
| Giercksky, KE; Lundblad, R | 1 |
| Harris, SP; Muder, RR; Nguyen, MH; Pasculle, AW | 1 |
| Pepe, R; Wood, CA | 1 |
| Baumgartner, JD; Chopart, P; Cometta, A; Eggimann, P; Herter, C; Huber, O; Lew, D; Pittet, D; Schaad, U; Zimmerli, W | 1 |
| Andremont, A; Carbon, C; Massias, L; Montravers, P | 1 |
| Cheng, AF; French, GL; Lam, AW; Ling, JM | 1 |
| Craft, AW; Gray, JW; Kernahan, J; Pearson, AD; Pedler, SJ; Windebank, KP | 1 |
| Chmel, H; Sanders, CC; Thomson, KS | 1 |
| Jones, RN; Sader, HS | 1 |
| Eppes, SC; Klein, JD | 1 |
| Dalhoff, A; Nitsche, D; Oesser, S; Sack, M; Schulze, C | 1 |
| Cisterna, R; Farga, MA; Garau, J; García-de-Lomas, J; Gimeno, C; Millás, E; Navarro, D; Savall, F | 1 |
| Antony, SJ; Matherin, P; Stratton, C | 1 |
| Benaissa-Trouw, B; Frasa, H; Hustinx, W; Kraaijeveld, K; Schellekens, J; Tavares, L; van Kessel, K; Verhoef, J | 1 |
| Bleichrodt, RP; Kooi, K; Rosman, C; van Oeveren, W; Westerveld, GJ | 1 |
| Bucklin, SE; Morrison, DC | 1 |
| Drgona, L; Grausova, S; Koren, P; Krcmery, V; Krupova, I; Kukuckova, E; Kunova, A; Lacka, J; Oravcova, E; Sevcikova, L; Spanik, S; Stopkova, K; Studena, M; Svec, J; Trup, J | 1 |
| Grausova, S; Koren, P; Krcmery, V; Krupova, I; Kukuckova, E; Kunova, A; Lacka, J; Spanik, S; Trupl, J | 1 |
| Bezáková, I; Drgona, L; Grausová, S; Hel'pianska, L; Ilavská, I; Koren, P; Krcméry, V; Krupová, I; Kukucková, E; Kunová, A; Lacka, J; Oravcová, E; Sevcíková, L; Spánik, S; Stopková, K; Studená, M; Svec, J; Trupl, J | 1 |
| Keil, S; Wiedemann, B | 1 |
| Fujita, Y; Fukabori, T; Mizobuchi, K; Nakamura, M; Takashina, R; Takizawa, H | 1 |
| Cetron, MS; Crane, GL; Finelli, L; Jarvis, WR; Paul, SM; Tokars, JI | 1 |
| Garnache, F; Goffinet, P; Simon, M | 1 |
| Alcaide, F; Carratalà, J; Fernández-Sevilla, A; Gudiol, F; Rosón, B | 1 |
| Lopez, SM; Rowen, JL | 1 |
| Boothe, DM; Boothe, HW; Howe, LM | 1 |
| Başkan, S; Ozyilkan, O; Yalçintaş, U | 1 |
| Geddes, A; Härkönen, M; Jacobs, F; Nowotny, I; Schonwald, S; Thaler, M | 1 |
| Angus, BJ; Chaowagul, W; Prins, JM; Simpson, AJ; Smith, MD; Suputtamongkol, Y; van Deventer, SJ; Weverling, GJ; White, NJ | 1 |
| Barbarini, D; Carretto, E; Emmi, V; Marone, P; Marzani, FC; Poletti, F | 1 |
| Böswald, M; Döbig, C; Guggenbichler, JP; Kändler, C; Krüger, C; Scharf, J; Soergel, F; Zink, S | 1 |
| Lumbiganon, P; Panamonta, O | 1 |
| Jellison, TK; Mckinnon, PS; Rybak, MJ | 1 |
| Laynez, P; Martínez, A; Miguélez, M; Romero, R | 1 |
| Becerril, B; Caballero-Granado, FJ; Cisneros, JM; Cuberos, L; Moreno, I; Pachón, J | 1 |
| Weinstein, MP | 1 |
| Byl, B; Clevenbergh, P; Jacobs, F; Kentos, A; Marchant, A; Thys, JP; Vincent, JL | 1 |
| Cid, A; Jarque, I; Martín, G; Pérez-Bellés, C; Salavert, M; Sanz, MA | 1 |
| Craft, AW; Gray, JW; Kernahan, J; Pearson, AD; Pedler, S | 1 |
| Goodwin, CS; Nsanze, H; Topley, J; Varady, E; Worsley, BW | 1 |
| Chow, JW; Shlaes, DM | 1 |
3 review(s) available for imipenem, anhydrous and Bacteremia
| Article | Year |
|---|---|
Syphilis-associated septic cardiomyopathy: case report and review of the literature.
Topics: Anti-Bacterial Agents; Bacteremia; Biomarkers; Cardiomyopathies; Echocardiography; Humans; Imipenem; Male; Middle Aged; Syphilis; Syphilis Serodiagnosis; Treponema pallidum | 2021 |
Bacteremia due to Campylobacter in renal transplantation: a case report and review of literature.
Topics: Anti-Bacterial Agents; Bacteremia; Campylobacter Infections; Humans; Imipenem; Kidney Transplantation; Male; Middle Aged | 2014 |
Antimicrobial treatment of Capnocytophaga infections.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Capnocytophaga; Cilastatin; Clindamycin; Endocarditis, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Immunocompromised Host; Microbial Sensitivity Tests | 2007 |
14 trial(s) available for imipenem, anhydrous and Bacteremia
| Article | Year |
|---|---|
Efficacy and safety of fosfomycin plus imipenem versus vancomycin for complicated bacteraemia and endocarditis due to methicillin-resistant Staphylococcus aureus: a randomized clinical trial.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Endocarditis; Female; Fosfomycin; Humans; Imipenem; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome; Vancomycin | 2018 |
Activity of doripenem versus comparators in subjects with baseline bacteraemia in six pooled phase 3 clinical trials.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Doripenem; Female; Humans; Imipenem; Intraabdominal Infections; Male; Meropenem; Ofloxacin; Pneumonia; Thienamycins; Treatment Outcome; Urinary Tract Infections | 2013 |
Efficacy and safety of fosfomycin plus imipenem as rescue therapy for complicated bacteremia and endocarditis due to methicillin-resistant Staphylococcus aureus: a multicenter clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Blood; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Endocarditis, Bacterial; Female; Fosfomycin; Humans; Imipenem; Infusions, Intravenous; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Salvage Therapy; Spain; Staphylococcal Infections; Treatment Outcome | 2014 |
Population pharmacokinetics and dosing simulations of imipenem in serious bacteraemia in immunocompromised patients with febrile neutropenia.
Topics: Acinetobacter; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Escherichia coli; Febrile Neutropenia; Female; Humans; Imipenem; Immunocompromised Host; Infusions, Intravenous; Klebsiella; Male; Middle Aged; Monte Carlo Method; Pseudomonas aeruginosa; Severity of Illness Index; Young Adult | 2015 |
Bacteremia due to Klebsiella pneumoniae isolates producing the TEM-52 extended-spectrum beta-lactamase: treatment outcome of patients receiving imipenem or ciprofloxacin.
Topics: Bacteremia; beta-Lactamases; Ciprofloxacin; Drug Resistance, Bacterial; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome | 2004 |
Impact of carbapenem administration on systemic endotoxemia in patients with severe sepsis and Gram-negative bacteremia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; C-Reactive Protein; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Endotoxemia; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Interleukin-6; Lipopolysaccharides; Male; Middle Aged; Pneumonia, Ventilator-Associated; Sepsis | 2006 |
Clinical outcome of febrile neutropenia in children with cancer using ceftazidime and aminoglycosides.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteremia; Ceftazidime; Child; Child, Preschool; Disease-Free Survival; Female; Gentamicins; Guidelines as Topic; Humans; Imipenem; Infant; Male; Neoplasms; Neutropenia; Prospective Studies; Survival Rate | 2007 |
Antibiotic-induced endotoxin release in patients with gram-negative urosepsis: a double-blind study comparing imipenem and ceftazidime.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; Ceftazidime; Double-Blind Method; Endotoxins; Enterobacter cloacae; Escherichia coli; Gram-Negative Bacterial Infections; Humans; Imipenem; Interleukin-6; Interleukin-8; Klebsiella pneumoniae; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Tumor Necrosis Factor-alpha; Urinary Tract Infections | 1995 |
Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients.
Topics: Adult; Aged; Bacteremia; Bacterial Infections; Cross Infection; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Netilmicin; Peritonitis; Pneumonia; Prospective Studies | 1994 |
[Effect of imipenem/cilastatin combined with vancomycin for MRSA infection].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Methicillin Resistance; Middle Aged; Pneumonia, Staphylococcal; Staphylococcal Infections; Urinary Tract Infections; Vancomycin | 1997 |
Imipenem-cilastatin versus sulbactam-cefoperazone plus amikacin in the initial treatment of febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacteremia; Cefoperazone; Cilastatin; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Sulbactam | 1999 |
Levofloxacin in the empirical treatment of patients with suspected bacteraemia/sepsis: comparison with imipenem/cilastatin in an open, randomized trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteremia; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Levofloxacin; Middle Aged; Ofloxacin; Protease Inhibitors; Sepsis; Thienamycins | 1999 |
Prognostic value of cytokine concentrations (tumor necrosis factor-alpha, interleukin-6, and interleukin-10) and clinical parameters in severe melioidosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; APACHE; Bacteremia; Biomarkers; Burkholderia pseudomallei; Ceftazidime; Cephalosporins; Cytokines; Female; Humans; Imipenem; Interleukin-10; Interleukin-6; Lactates; Logistic Models; Male; Melioidosis; Middle Aged; Prognosis; Thienamycins; Tumor Necrosis Factor-alpha | 2000 |
Ceftazidime- and imipenem-induced endotoxin release during treatment of gram-negative infections.
Topics: Bacteremia; Ceftazidime; Drug Administration Schedule; Endotoxins; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Injections, Intravenous; Interleukin-6; Male; Probability; Reference Values; Sensitivity and Specificity; Statistics, Nonparametric; Tumor Necrosis Factor-alpha | 2001 |
156 other study(ies) available for imipenem, anhydrous and Bacteremia
| Article | Year |
|---|---|
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Predictive Value of Tests; Proteus mirabilis; Risk Factors; Survival Analysis; Treatment Outcome | 2007 |
Enterobacteriaceae bloodstream infections: presence of integrons, risk factors, and outcome.
Topics: Bacteremia; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Humans; Infectious Disease Transmission, Professional-to-Patient; Integrons; Microbial Sensitivity Tests; Nucleic Acid Amplification Techniques; Polymerase Chain Reaction; Prospective Studies; Risk Factors; Sequence Analysis, DNA; Treatment Outcome | 2007 |
Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; beta-Lactams; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Fluoroquinolones; Genotype; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Reverse Transcriptase Polymerase Chain Reaction | 2007 |
Development of colistin-dependent Acinetobacter baumannii-Acinetobacter calcoaceticus complex.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Aged; Anti-Bacterial Agents; Bacteremia; Calcaneus; Colistin; Humans; Male; Microbial Sensitivity Tests; Osteomyelitis | 2007 |
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Risk Factors; Treatment Failure | 2008 |
Phenotypic and enzymatic comparative analysis of the novel KPC variant KPC-5 and its evolutionary variants, KPC-2 and KPC-4.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Drug Resistance, Bacterial; Enzyme Inhibitors; Genetic Variation; Hydrolysis; Isoelectric Focusing; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phenotype; Protein Isoforms; Reverse Transcriptase Polymerase Chain Reaction | 2009 |
Nonclonal emergence of colistin-resistant Klebsiella pneumoniae isolates from blood samples in South Korea.
Topics: Anti-Bacterial Agents; Bacteremia; Colistin; Cross Infection; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Population Surveillance; Republic of Korea | 2010 |
Microbiologic and clinical implications of bacteremia due to extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae with or without plasmid-mediated AmpC beta-lactamase DHA-1.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Case-Control Studies; Ciprofloxacin; Female; Humans; Klebsiella pneumoniae; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Plasmids; Young Adult | 2010 |
New options for bloodstream infections caused by colistin- or ceftazidime/avibactam-resistant Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacteremia; beta-Lactamase Inhibitors; Boronic Acids; Carbapenem-Resistant Enterobacteriaceae; Ceftazidime; Cilastatin; Colistin; Drug Combinations; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Tetracyclines | 2021 |
Effectiveness and antimicrobial susceptibility profiles during primary antimicrobial prophylaxis for pediatric acute myeloid leukemia.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Bacteremia; Child; Ciprofloxacin; Febrile Neutropenia; Female; Humans; Imipenem; Leukemia, Myeloid, Acute; Male; Mycoses; Vancomycin; Voriconazole | 2021 |
Clinical and molecular characteristics and risk factors for patients acquiring carbapenemase-producing and non-carbapenemase-producing carbapenem-nonsusceptible-Enterobacterales bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Humans; Imipenem; Microbial Sensitivity Tests; Multilocus Sequence Typing; Risk Factors | 2022 |
Changing Patterns of Causative Pathogens over Time and Efficacy of Empirical Antibiotic Therapies in Acute Cholangitis with Bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; Cholangitis; Humans; Imipenem; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Retrospective Studies | 2022 |
Accurate Identification and Virulence Detection of Aeromonas: a Single-Center Retrospective Study on the Clinical Features and Outcomes Associated with Aeromonas Bacteremia in Southwestern China.
Topics: Aeromonas; Anti-Bacterial Agents; Bacteremia; Hematologic Neoplasms; Humans; Imipenem; Retrospective Studies; Virulence | 2023 |
Characteristics of invasive Acinetobacter infection: A multicenter investigation with molecular identification of causative organisms.
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Child; Child, Preschool; Drug Resistance, Bacterial; Female; Humans; Imipenem; Infant; Infant, Newborn; Japan; Male; Meningitis; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Factors; Shock, Septic; Young Adult | 2020 |
Extensively drug-resistant Alcaligenes faecalis infection.
Topics: Adult; Aged; Aged, 80 and over; Alcaligenes faecalis; Anti-Bacterial Agents; Bacteremia; Ceftazidime; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome | 2020 |
The prediction values of carbapenemase detection methods and carbapenem susceptibility testing for clinical outcomes of patients with Acinetobacter bacteremia under carbapenem treatment.
Topics: Acinetobacter; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Humans; Imipenem; Microbial Sensitivity Tests; Retrospective Studies | 2022 |
Clinical Characteristics, Risk Factors, and Outcomes of Patients with Polymicrobial
Topics: Adult; Aged; Bacteremia; Carbapenems; Ertapenem; Female; Hospitalization; Humans; Imipenem; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Odds Ratio; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2021 |
Bacteremia caused by Elizabethkingia meningoseptica in a mechanically ventilated patient successfully treated with imipenem-cilastatin and ciprofloxacin.
Topics: Anti-Bacterial Agents; Bacteremia; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Flavobacteriaceae Infections; Humans; Imipenem; Male; Middle Aged | 2017 |
Clinical Outcome and Antimicrobial Therapeutic Drug Monitoring for the Treatment of Infections in Acute Burn Patients.
Topics: Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Burns; Child; Child, Preschool; Cross Infection; Drug Monitoring; Female; Humans; Imipenem; Infant; Intensive Care Units; Male; Meropenem; Middle Aged; Piperacillin; Pneumonia; Prognosis; Tertiary Care Centers; Thienamycins; Urinary Tract Infections; Vancomycin; Young Adult | 2017 |
Empiric antibiotic protocols for cancer patients with neutropenia: a single-center study of treatment efficacy and mortality in patients with bacteremia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Cefazolin; Clinical Protocols; Enterobacteriaceae Infections; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus | 2018 |
Risk factors and molecular epidemiology of Acinetobacter baumannii bacteremia in neonates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Male; Microbial Sensitivity Tests; Minocycline; Molecular Epidemiology; Multilocus Sequence Typing; Polymerase Chain Reaction; Risk Factors; Taiwan; Tigecycline | 2018 |
Effect of elevated imipenem/cilastatin minimum inhibitory concentrations on patient outcomes in Gram-negative bloodstream infections.
Topics: Aged; Bacteremia; Cilastatin; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome | 2018 |
High Prevalence of CTX-M-15-Type Extended-Spectrum β-Lactamase Among AmpC β-Lactamase-Producing Klebsiella pneumoniae Isolates Causing Bacteremia in Korea.
Topics: Bacteremia; Bacterial Proteins; beta-Lactamases; Genes, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Plasmids; Republic of Korea | 2018 |
In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstream
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Azabicyclo Compounds; Bacteremia; Cefiderocol; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Stenotrophomonas maltophilia; Taiwan; Tazobactam | 2019 |
High prevalence of division II (cfiA positive) isolates among blood stream Bacteroides fragilis in Slovenia as determined by MALDI-TOF MS.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Bacteriological Techniques; Bacteroides fragilis; Bacteroides Infections; beta-Lactam Resistance; beta-Lactamases; Child; Child, Preschool; Female; Humans; Imipenem; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Retrospective Studies; Slovenia; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Young Adult | 2019 |
Potentiation of imipenem by relebactam for Pseudomonas aeruginosa from bacteraemia and respiratory infections.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacteremia; Drug Resistance, Bacterial; Drug Synergism; Humans; Imipenem; Microbial Sensitivity Tests; Phenotype; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections | 2019 |
Activity of Imipenem-Relebactam and Comparator Agents against Genetically Characterized Isolates of Carbapenem-Resistant Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacteremia; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Ceftazidime; Drug Combinations; Enterobacteriaceae Infections; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2019 |
Risk factors and outcomes of imipenem-resistant Acinetobacter bloodstream infection in North-Eastern Malaysia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Case-Control Studies; Cross-Sectional Studies; Female; Hospitals, Teaching; Humans; Imipenem; Malaysia; Male; Middle Aged; Risk Factors; Treatment Outcome; Young Adult | 2011 |
Risk factors for imipenem-nonsusceptible Acinetobacter nosocomialis bloodstream infection.
Topics: Academic Medical Centers; Acinetobacter; Acinetobacter Infections; Aged; Aged, 80 and over; Bacteremia; beta-Lactam Resistance; Cross Infection; Female; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Odds Ratio; Retrospective Studies; Risk Factors | 2014 |
Septic shock due to Rhodococcus equi in a patient with chronic myelomonocytic leukemia.
Topics: Actinomycetales Infections; Aged; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Diagnosis, Differential; Drug Therapy, Combination; Fertilizers; Humans; Imipenem; Immunocompromised Host; Leukemia, Myelomonocytic, Chronic; Lung Abscess; Lung Neoplasms; Male; Manure; Opportunistic Infections; Rhodococcus equi; Rifampin; Shock, Septic; Tomography, X-Ray Computed | 2013 |
Bacteremia due to imipenem-resistant Roseomonas mucosa in a child with acute lymphoblastic leukemia.
Topics: Anti-Bacterial Agents; Bacteremia; Child; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Methylobacteriaceae; Mucous Membrane; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prognosis | 2014 |
A mouse model of Acinetobacter baumannii-associated pneumonia using a clinically isolated hypervirulent strain.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Bacteremia; Bacterial Vaccines; Body Weight; Bronchopneumonia; Disease Models, Animal; Female; Imipenem; Immunization; Lung; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microbial Sensitivity Tests; Minocycline; Pneumonia, Bacterial; Reproducibility of Results; Tigecycline; Time Factors | 2013 |
[Infective endocarditis by Rhizobium radiobacter. A case report].
Topics: Agrobacterium tumefaciens; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Equipment Contamination; Gram-Negative Bacterial Infections; Humans; Imipenem; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Subclavian Vein; Tricuspid Valve Insufficiency; Vancomycin | 2013 |
[Endogenous endophthalmitis as a complication in erysipelas].
Topics: Antifungal Agents; Bacteremia; Ceftazidime; Diabetes Mellitus, Type 2; Disease Susceptibility; Drug Therapy, Combination; Endophthalmitis; Erysipelas; Eye Infections, Bacterial; Humans; Imipenem; Intertrigo; Leg; Levofloxacin; Male; Middle Aged; Obesity; Streptococcus agalactiae; Uveitis, Anterior; Vancomycin | 2013 |
[Investigation of plasmid mediated AmpC beta-lactamases among Escherichia coli and Klebsiella pneumoniae isolated from blood cultures].
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Cefotaxime; Cefoxitin; Ceftazidime; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Plasmids | 2013 |
Risk factors and outcome analysis of acinetobacter baumannii complex bacteremia in critical patients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; Critical Illness; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Imipenem; Intensive Care Units; Kaplan-Meier Estimate; Male; Multivariate Analysis; Pneumonia, Ventilator-Associated; Polymerase Chain Reaction; Retrospective Studies; Risk Factors; RNA, Ribosomal, 16S; Tertiary Care Centers; Treatment Outcome | 2014 |
Diversity of β-lactamases produced by imipenem resistant, Pseudomonas aeruginosa isolates from the bloodstream.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Child; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Iran; Male; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2014 |
Molecular and epidemiological characterization of IMP-type metallo-β-lactamase-producing Enterobacter cloacae in a Large tertiary care hospital in Japan.
Topics: Aged; Aged, 80 and over; Bacteremia; Bacterial Proteins; beta-Lactamases; Cephalosporins; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Hospital Mortality; Humans; Imipenem; Infection Control; Inosine Monophosphate; Japan; Male; Meropenem; Middle Aged; Phylogeny; R Factors; Retrospective Studies; Risk Factors; Tertiary Healthcare; Thienamycins | 2014 |
The deadly impact of extreme drug resistance in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; Female; Humans; Imipenem; Male | 2014 |
The impact of possible clonal spread of Acinetobacter baumannii complex bacteremia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; Female; Humans; Imipenem; Male | 2014 |
The authors reply.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; Female; Humans; Imipenem; Male | 2014 |
Emergence in Taiwan of novel imipenem-resistant Acinetobacter baumannii ST455 causing bloodstream infection in critical patients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Bacteremia; Cross Infection; DNA, Intergenic; Drug Resistance, Bacterial; Female; Humans; Imipenem; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Taiwan | 2015 |
Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; Cephalosporins; Ciprofloxacin; Cross Infection; Female; Hospitals; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Mortality; Multivariate Analysis; Odds Ratio; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Severity of Illness Index; Taiwan; Thienamycins | 2017 |
Trends in Susceptibility Rates and Extended-Spectrum β-Lactamase Production of Klebsiella pneumoniae in Bloodstream Infections Across the United States Veterans Affairs Healthcare System.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Cefepime; Cefoxitin; Ceftazidime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Ertapenem; Fluoroquinolones; Gene Expression Regulation, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sulbactam; United States; United States Department of Veterans Affairs | 2015 |
Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of cl
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Female; Hospital Mortality; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Pneumonia, Ventilator-Associated; Salvage Therapy; Sulbactam; Taiwan; Tigecycline; Treatment Outcome | 2016 |
Efficacy of Single and Combined Antibiotic Treatments of Anthrax in Rabbits.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Bacteremia; Ciprofloxacin; Clarithromycin; Disease Models, Animal; Doxycycline; Drug Combinations; Drug Synergism; Humans; Imipenem; Linezolid; Male; Microbial Sensitivity Tests; Rabbits; Respiratory Tract Infections; Rifampin; Spores, Bacterial; Survival Analysis; Vancomycin | 2015 |
A retrospective study of the incidence, clinical characteristics, identification, and antimicrobial susceptibility of bacteremic isolates of Acinetobacter ursingii.
Topics: Acinetobacter; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Ceftazidime; Ceftriaxone; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Humans; Imipenem; Incidence; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Phenotype; Retrospective Studies; RNA, Ribosomal, 16S | 2015 |
Mutational inactivation of OprD in carbapenem-resistant Pseudomonas aeruginosa isolates from Korean hospitals.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Meropenem; Multidrug Resistance-Associated Proteins; Mutation; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Republic of Korea; Thienamycins | 2016 |
Combination Regimens for Treatment of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Cephalosporins; Drug Therapy, Combination; Female; Humans; Imipenem; Immunosuppressive Agents; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Retrospective Studies; Survival Analysis; Thienamycins; Treatment Outcome | 2016 |
Overproduction of active efflux pump and variations of OprD dominate in imipenem-resistant Pseudomonas aeruginosa isolated from patients with bloodstream infections in Taiwan.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Codon, Terminator; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; INDEL Mutation; Microbial Sensitivity Tests; Point Mutation; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Taiwan | 2016 |
Rapid increase in resistance to third generation cephalosporins, imipenem and co-resistance in Klebsiella pneumoniae from isolated from 7,140 blood-cultures (2010-2014) using EARS-Net data in Spain.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Catchment Area, Health; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Population Surveillance; Spain; Young Adult | 2017 |
[Invasive Campylobacter jejuni/coli Infections: 9 Case Reports at a Single Center between 2000 and 2015, and a Review of Literature Describing Japanese Patients].
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Campylobacter Infections; Campylobacter jejuni; Child; Child, Preschool; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Japan; Male; Microbial Sensitivity Tests; Middle Aged; Young Adult | 2016 |
Universal protocol for the rapid automated detection of carbapenem-resistant Gram-negative bacilli directly from blood cultures by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF/MS).
Topics: Anti-Bacterial Agents; Automation, Laboratory; Bacteremia; beta-Lactam Resistance; Blood Culture; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Hydrolysis; Imipenem; Microbial Sensitivity Tests; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Time Factors | 2016 |
Late Therapeutic Intervention with Antibiotics and Fluid Resuscitation Allows for a Prolonged Disease Course with High Survival in a Severe Murine Model of Sepsis.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Cytokines; Disease Models, Animal; Fluid Therapy; Imipenem; Male; Mice; Mice, Inbred C57BL; Sepsis | 2017 |
[Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance].
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Bacteriological Techniques; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Gentamicins; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Retrospective Studies; Thienamycins; Wound Infection | 2009 |
Imipenem/cilastatin with or without glycopeptide as initial antibiotic therapy for recipients of autologous stem cell transplantation: results of a Spanish multicenter study.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cilastatin; Disease-Free Survival; Female; Glycopeptides; Hematologic Neoplasms; Humans; Imipenem; Male; Middle Aged; Neutropenia; Protease Inhibitors; Retrospective Studies; Spain; Stem Cell Transplantation; Survival Rate; Teicoplanin; Transplantation, Autologous; Vancomycin | 2009 |
Clinical impact of imipenem-resistant Pseudomonas aeruginosa bloodstream infections.
Topics: Adult; Aged; Analysis of Variance; Bacteremia; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Hospitals, Teaching; Humans; Imipenem; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies | 2009 |
First isolation of Burkholderia tropica from a neonatal patient successfully treated with imipenem.
Topics: Anti-Bacterial Agents; Bacteremia; Burkholderia; Burkholderia Infections; Fatal Outcome; Humans; Imipenem; Immunocompromised Host; Infant, Newborn; Infant, Premature; Male; Risk Factors | 2010 |
[Alcaligenes xylosoxidans bacteremia in a patient with acute lymphoblastic leukemia].
Topics: Alcaligenes; Anti-Bacterial Agents; Bacteremia; Child, Preschool; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Microbial Sensitivity Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2009 |
Comparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study.
Topics: Anti-Bacterial Agents; Bacteremia; France; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Thienamycins; Wound Infection | 2010 |
Imipenem-resistant Campylobacter fetus bloodstream infection.
Topics: Anti-Bacterial Agents; Bacteremia; Campylobacter fetus; Campylobacter Infections; Drug Resistance, Bacterial; Humans; Imipenem; In Vitro Techniques; Liver Transplantation; Male; Middle Aged | 2010 |
Nosocomial imipenem-resistant Acinetobacter baumannii infections: epidemiology and risk factors.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Incidence; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Respiration, Artificial; Risk Factors | 2010 |
Patients with Acinetobacter baumannii bloodstream infections are colonized in the gastrointestinal tract with identical strains.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; beta-Lactam Resistance; Blood; Critical Illness; Cross Infection; DNA Fingerprinting; Electrophoresis, Gel, Pulsed-Field; Female; Gastrointestinal Tract; Humans; Imipenem; Male; Middle Aged; Molecular Epidemiology | 2010 |
In vitro and in vivo activities of linezolid alone and combined with vancomycin and imipenem against Staphylococcus aureus with reduced susceptibility to glycopeptides.
Topics: Acetamides; Animals; Ascitic Fluid; Bacteremia; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Glycopeptides; Imipenem; Linezolid; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Oxazolidinones; Peritonitis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2010 |
Clinical characteristics and outcomes of bacteraemic melioidosis in a teaching hospital in a northeastern state of Malaysia: a five-year review.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Burkholderia pseudomallei; Ceftazidime; Female; Hospitals, Teaching; Humans; Imipenem; Liver Abscess; Malaysia; Male; Melioidosis; Middle Aged; Pneumonia, Bacterial; Testicular Hydrocele; Treatment Outcome; Young Adult | 2010 |
Efficacy of fosfomycin and its combination with linezolid, vancomycin and imipenem in an experimental peritonitis model caused by a Staphylococcus aureus strain with reduced susceptibility to vancomycin.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Ascitic Fluid; Bacteremia; Bacterial Load; Disease Models, Animal; Drug Therapy, Combination; Female; Fosfomycin; Humans; Imipenem; Linezolid; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Oxazolidinones; Peritonitis; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2011 |
Antimicrobial activity of doripenem and other carbapenems against gram-negative pathogens from Korea.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Doripenem; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Korea; Meropenem; Microbial Sensitivity Tests; Republic of Korea; Thienamycins; Urinary Tract Infections | 2011 |
Pseudomonas aeruginosa bacteremia: resistance to antibiotics, risk factors, and patient mortality.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Data Interpretation, Statistical; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Imipenem; Intensive Care Units; Lithuania; Male; Meropenem; Middle Aged; Odds Ratio; Pseudomonas aeruginosa; Pseudomonas Infections; Respiration, Artificial; Retrospective Studies; Risk Factors; Thienamycins; Time Factors | 2010 |
Antibiotics cure anthrax in animal models.
Topics: Animals; Anthrax; Anthrax Vaccines; Anti-Bacterial Agents; Antigens, Bacterial; Bacillus anthracis; Bacteremia; Doxycycline; Enzyme-Linked Immunosorbent Assay; Gentamicins; Guinea Pigs; Imipenem; Ofloxacin; Rabbits | 2011 |
Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Thienamycins; Treatment Outcome | 2011 |
Physicians fail to consider Pseudomonas aeruginosa as a potential pathogen in medicine patients with bacteremia.
Topics: Bacteremia; Drug Resistance, Bacterial; Female; Humans; Imipenem; Male; Pseudomonas aeruginosa; Pseudomonas Infections | 2011 |
[Comparative evaluation of in vitro activities of carbapenems against gram-negative pathogens: Turkish data of COMPACT study].
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Thienamycins; Turkey | 2011 |
Changes in antimicrobial susceptibility and major clones of Acinetobacter calcoaceticus-baumannii complex isolates from a single hospital in Korea over 7 years.
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Genotype; Hospitals; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Republic of Korea; Species Specificity; Thienamycins | 2012 |
Risk factors for bacteraemia attributable to Pseudomonas aeruginosa resistant to imipenem, levofloxacin, or gentamicin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Female; Gentamicins; Humans; Imipenem; Infant; Infant, Newborn; Levofloxacin; Male; Middle Aged; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Young Adult | 2011 |
Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea.
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; Carbapenems; Cross Infection; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Real-Time Polymerase Chain Reaction; Republic of Korea | 2012 |
In vitro time-kill studies of antimicrobial agents against blood isolates of imipenem-resistant Acinetobacter baumannii, including colistin- or tigecycline-resistant isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Blood; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Imipenem; Microbial Sensitivity Tests; Microbial Viability; Minocycline; Tigecycline; Time Factors | 2012 |
Ertapenem in the treatment of bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli: a propensity score analysis.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Escherichia coli; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Propensity Score; Thienamycins | 2012 |
Efficacy of imipenem for the treatment of bacteremia due to an OXA-48-producing Klebsiella pneumoniae isolate.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; DNA, Bacterial; Female; Genotype; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome | 2012 |
Tsukamurella tyrosinosolvens intravascular catheter-related bacteremia in a haematology patient: a case report.
Topics: Actinomycetales; Actinomycetales Infections; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Catheterization, Central Venous; Female; Humans; Imipenem; Leukemia, Myeloid, Acute; Methicillin-Resistant Staphylococcus aureus; Middle Aged; RNA, Bacterial; RNA, Ribosomal, 16S | 2011 |
Comparative Activity of Carbapenem Testing (COMPACT) study in Germany.
Topics: Bacteremia; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Germany; Humans; Imipenem; Intensive Care Units; Intraabdominal Infections; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Quality Control; Thienamycins | 2012 |
Carbapenem therapy for bacteremia due to extended-spectrum-β-lactamase-producing Escherichia coli or Klebsiella pneumoniae: implications of ertapenem susceptibility.
Topics: Adult; Bacteremia; beta-Lactams; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Retrospective Studies; Thienamycins; Young Adult | 2012 |
Investigation and control of an outbreak of imipenem-resistant Acinetobacter baumannii Infection in a Pediatric Intensive Care Unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Child; Child, Preschool; Cross Infection; Disease Outbreaks; Environmental Microbiology; Female; Humans; Imipenem; Infant; Infant, Newborn; Infection Control; Intensive Care Units, Pediatric; Male; Republic of Korea; Young Adult | 2012 |
OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Gene Silencing; Genes, Bacterial; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Mutation; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Republic of Korea; Reverse Transcriptase Polymerase Chain Reaction; Thienamycins; Urinary Tract Infections | 2012 |
Activities of doripenem against nosocomial bacteremic drug-resistant Gram-negative bacteria in a medical center in Taiwan.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Enterobacteriaceae; Gram-Negative Bacteria; Hospitals, University; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Taiwan; Thienamycins | 2012 |
Cross-infection due to imipenem-resistant Bacteroides fragilis associated with a totally implantable venous port.
Topics: Adult; Aged; Aged, 80 and over; Bacteremia; Bacterial Proteins; Bacterial Typing Techniques; Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; Catheterization, Central Venous; Cross Infection; DNA, Bacterial; Drug Resistance, Bacterial; Female; Genotype; Humans; Imipenem; Male; Middle Aged; Molecular Sequence Data; Neoplasms; Sequence Analysis, DNA; Thienamycins | 2002 |
Disseminated Mycobacterium peregrinum infection in a child with complete interferon-gamma receptor-1 deficiency.
Topics: Bacteremia; Capreomycin; Drug Therapy, Combination; Follow-Up Studies; Humans; Imipenem; Immunocompromised Host; Infant; Interferon gamma Receptor; Italy; Male; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Receptors, Interferon; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2003 |
Antibiotics delay but do not prevent bacteremia and lung injury in murine sepsis.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Female; Imipenem; Mice; Mice, Inbred C57BL; Prospective Studies; Random Allocation; Respiratory Distress Syndrome; Sepsis; Time Factors | 2004 |
Virulence of metallo-beta-lactamase-producing Pseudomonas aeruginosa in vitro and in vivo.
Topics: Animals; Bacteremia; beta-Lactamases; Ceftazidime; Cephalosporins; Cilastatin; Ciprofloxacin; Drug Therapy, Combination; Imipenem; Leukopenia; Male; Mice; Mice, Inbred BALB C; Protease Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Stem Cells; Thienamycins | 2004 |
Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Drug Resistance, Bacterial; Drug Utilization; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Multivariate Analysis | 2004 |
Nosocomial bloodstream infections with Burkholderia stabilis.
Topics: Adolescent; Adult; Aged; Bacteremia; Bacterial Typing Techniques; Burkholderia; Burkholderia Infections; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Hospital Mortality; Hospitals, University; Humans; Imipenem; Infection Control; Intensive Care Units; Male; Middle Aged; Opportunistic Infections; Random Amplified Polymorphic DNA Technique; Retrospective Studies; Risk Factors; Treatment Outcome; Turkey | 2005 |
RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Cefazolin; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Imipenem; Male; Mice; Mice, Inbred BALB C; Oligopeptides; Random Allocation; Sensitivity and Specificity; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Vancomycin | 2005 |
IMPs, VIMs and SPMs: the diversity of metallo-beta-lactamases produced by carbapenem-resistant Pseudomonas aeruginosa in a Brazilian hospital.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Brazil; Carbapenems; Hospitals, Teaching; Humans; Imipenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Polymyxins; Pseudomonas aeruginosa; Pseudomonas Infections | 2005 |
Characterization of a new integron containing bla(VIM-1) and aac(6')-IIc in an Enterobacter cloacae clinical isolate from Greece.
Topics: Acetyltransferases; Aged; Amino Acid Sequence; Bacteremia; beta-Lactamases; beta-Lactams; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Greece; Humans; Imipenem; Integrons; Lactams; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction | 2005 |
Risk factors for antimicrobial resistance and influence of resistance on mortality in patients with bloodstream infection caused by Pseudomonas aeruginosa.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Drug Resistance, Bacterial; Female; Hospital Mortality; Humans; Imipenem; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors | 2005 |
Differences in the proportions of fluoroquinolone-resistant Gram-negative bacteria isolated from bacteraemic children with cancer in two Italian centres.
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Ceftazidime; Child; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, Pediatric; Humans; Imipenem; Italy; Neoplasms; Retrospective Studies | 2005 |
Recurrent infections caused by cefotaxime- and ciprofloxacin-resistant Salmonella enterica serotype choleraesuis treated successfully with imipenem.
Topics: Anti-Bacterial Agents; Bacteremia; Cefotaxime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Middle Aged; Psoas Abscess; Recurrence; Salmonella enterica; Salmonella Infections; Spondylitis; Treatment Outcome; Uremia | 2005 |
Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infection due to Pseudomonas aeruginosa.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Systemic Inflammatory Response Syndrome; Time Factors | 2006 |
Imipenem/cilastatin as initial single-agent therapy for infections in cancer patients with neutropenia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Humans; Imipenem; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Neutropenia; Treatment Outcome | 1989 |
[Infections caused by Acinetobacter spp. in critically ill ICU patients].
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; APACHE; Bacteremia; beta-Lactam Resistance; Child; Comorbidity; Critical Illness; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Health Surveys; Hospital Mortality; Humans; Imipenem; Incidence; Intensive Care Units; Male; Middle Aged; Postoperative Complications; Prospective Studies; Prosthesis-Related Infections; Spain; Species Specificity | 2005 |
RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Biofilms; Catheterization, Central Venous; Catheters, Indwelling; Ciprofloxacin; Drug Therapy, Combination; Imipenem; Male; Microbial Sensitivity Tests; Oligopeptides; Rats; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2006 |
Use of bacteriophage in the treatment of experimental animal bacteremia from imipenem-resistant Pseudomonas aeruginosa.
Topics: Animals; Bacteremia; Bacteriophages; Disease Models, Animal; Drug Resistance, Bacterial; Female; Genetic Therapy; Imipenem; Mice; Mice, Inbred BALB C; Microscopy, Electron; Pseudomonas aeruginosa; Temperature | 2006 |
Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Intensive Care Units; Pneumonia, Bacterial; Urinary Tract Infections | 2006 |
Comparison of efficacy of cefoperazone/sulbactam and imipenem/cilastatin for treatment of Acinetobacter bacteremia.
Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cefoperazone; Cilastatin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Protease Inhibitors; Sulbactam | 2006 |
Treatment failure due to emergence of resistance to carbapenem during therapy for Shewanella algae bacteremia.
Topics: Aged; Bacteremia; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Polymerase Chain Reaction; Shewanella; Treatment Failure | 2006 |
Multidrug-resistant bacteria isolated from patients hospitalised in Intensive Care Units.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cross Infection; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Imipenem; Inpatients; Intensive Care Units; Length of Stay; Microbial Sensitivity Tests; Risk Factors | 2006 |
Evaluation of imipenem/imipenem+EDTA disk method for detection of metallo-beta-lactamase-producing Klebsiella pneumoniae isolated from blood cultures.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Edetic Acid; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2006 |
Clinical features and risk factors for mortality in Aeromonas bacteremic adults with hematologic malignancies.
Topics: Aeromonas; Aged; Aged, 80 and over; Antineoplastic Agents; Bacteremia; Consciousness Disorders; Drug Resistance, Bacterial; Female; Fever; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Hospitals; Humans; Imipenem; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelodysplastic Syndromes; Piperacillin; Prognosis; Risk Factors; Shock, Septic; Taiwan; Time Factors | 2006 |
Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia.
Topics: Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cohort Studies; Drug Resistance, Bacterial; Female; Humans; Imipenem; Male; Middle Aged; Multivariate Analysis; Retrospective Studies | 2007 |
VIM-1-producing Klebsiella pneumoniae bloodstream infections: analysis of 28 cases.
Topics: Adult; Aged; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Case-Control Studies; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Regression Analysis; Retrospective Studies; Survival Rate; Treatment Outcome | 2007 |
[Escherichia coli endocarditis: a report of two cases].
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Ceftriaxone; Combined Modality Therapy; Endocarditis, Bacterial; Escherichia coli Infections; Female; Gastroenteritis; Gentamicins; Heart Valve Prosthesis Implantation; Humans; Imipenem; Middle Aged; Urinary Tract Infections | 2007 |
Mice depleted of alphabeta but not gammadelta T cells are resistant to mortality caused by cecal ligation and puncture.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Bacteria; Cecum; Chemokine CXCL2; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Imipenem; Interleukin-6; Killer Cells, Natural; Ligation; Mice; Mice, Inbred C57BL; Mice, Knockout; Monokines; Punctures; Receptors, Antigen, T-Cell, alpha-beta; Receptors, Antigen, T-Cell, gamma-delta; Sepsis; T-Lymphocytes; Temperature; Time Factors | 2007 |
Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Bile Duct Diseases; Community-Acquired Infections; Cross Infection; Drug Resistance; England; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Length of Stay; Male; Middle Aged; Odds Ratio; Prospective Studies; Urinary Tract Infections | 2007 |
Spondylodiscitis associated with recurrent Serratia bacteremia due to a transjugular intrahepatic portosystemic shunt (TIPS): a case report.
Topics: Anti-Bacterial Agents; Bacteremia; Discitis; Humans; Imipenem; Male; Middle Aged; Portasystemic Shunt, Transjugular Intrahepatic; Serratia Infections; Serratia marcescens | 2007 |
Combination carbapenem-sulbactam therapy for critically ill patients with multidrug-resistant Acinetobacter baumannii bacteremia: four case reports and an in vitro combination synergy study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cilastatin; Cilastatin, Imipenem Drug Combination; Critical Illness; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Sulbactam; Taiwan; Thienamycins | 2007 |
Campylobacter fetus bloodstream infection: risk factors and clinical features.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; Campylobacter fetus; Campylobacter Infections; Cardiovascular Diseases; Diabetes Complications; Female; Humans; Imipenem; Immunocompromised Host; Male; Risk Factors; Treatment Outcome | 2008 |
Biofilm formation in Acinetobacter baumannii: associated features and clinical implications.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Biofilms; Catheters, Indwelling; Ciprofloxacin; Cohort Studies; Drug Resistance, Bacterial; Female; Humans; Imipenem; Male; Meningitis; Middle Aged; Urinary Tract Infections | 2008 |
Ecthyma gangrenosum: sign of Pseudomonas aeruginosa bacteremia.
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Child; Ecthyma; Female; Humans; Imipenem; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Pseudomonas aeruginosa; Pseudomonas Infections | 2008 |
Therapeutic efficacy of a polymyxin B-dextran 70 conjugate in experimental model of endotoxemia.
Topics: Animals; Bacteremia; Dextrans; Disease Models, Animal; Drug Carriers; Endotoxins; Escherichia coli Infections; Female; Galactosamine; Imipenem; Lipopolysaccharides; Mice; Polymyxin B; Toxemia | 1995 |
Infections due to Rhodococcus equi in three HIV-infected patients: microbiological findings and antibiotic susceptibility.
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Azithromycin; Bacteremia; Bronchoalveolar Lavage Fluid; Clarithromycin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; HIV Infections; Humans; Imipenem; Male; Pleurisy; Pneumonia, Bacterial; Rhodococcus equi; Rifampin; Sputum; Teicoplanin; Vancomycin | 1994 |
An outbreak of Enterobacter cloacae associated with contamination of a blood gas machine.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; Blood Gas Analysis; Cross Infection; Disease Outbreaks; Enterobacter cloacae; Enterobacteriaceae Infections; Equipment Contamination; Gentamicins; Humans; Imipenem; Infant; Infant, Newborn; Infection Control; Thienamycins | 1995 |
Simultaneous resistance to metronidazole, co-amoxiclav, and imipenem in clinical isolate of Bacteroides fragilis.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacteremia; Bacteroides fragilis; Bacteroides Infections; Clavulanic Acids; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Empyema, Pleural; Female; Humans; Imipenem; Metronidazole | 1995 |
Synergistic effect of E5, imipenem, and volume support during fulminant intraabdominal sepsis in rats.
Topics: Abdomen; Animals; Antibodies, Monoclonal; Bacteremia; Bacteria; Blood; Blood Volume; Death; Dehydration; Drug Synergism; Endotoxins; Imipenem; Immunoglobulin M; Lactates; Male; Mice; Rats; Rats, Wistar; Time Factors; Tumor Necrosis Factor-alpha | 1995 |
Antibiotic-resistant Acinetobacter meningitis in neurosurgical patients.
Topics: Acinetobacter Infections; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Bacteriological Techniques; Brain Diseases; Brain Neoplasms; Cross Infection; Drug Resistance, Microbial; Female; Humans; Imipenem; Male; Meningitis, Bacterial; Middle Aged; Postoperative Complications; Recurrence; Risk Factors; Surgical Wound Infection | 1994 |
Bacteremia in a patient with non-urinary-tract infection due to Corynebacterium urealyticum.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Corynebacterium Infections; Humans; Imipenem; Leukemia, Myeloid; Male; Vancomycin | 1994 |
Investigation of the potential role of Enterococcus faecalis in the pathophysiology of experimental peritonitis.
Topics: Abscess; Amoxicillin; Animals; Anti-Bacterial Agents; Bacteremia; Bacteroides fragilis; Bacteroides Infections; Body Weight; Disease Models, Animal; Drug Synergism; Enterococcus faecalis; Escherichia coli; Escherichia coli Infections; Gentamicins; Gram-Positive Bacterial Infections; Imipenem; Male; Microbial Sensitivity Tests; Ornidazole; Pefloxacin; Peritoneum; Peritonitis; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms | 1994 |
Activity of beta-lactam antibiotics in an animal model against methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Cefamandole; Imipenem; Male; Methicillin Resistance; Mice; Mice, Inbred ICR; Staphylococcal Infections; Staphylococcus aureus | 1993 |
Changing causes of septicaemia in paediatric oncology patients: effect of imipenem use.
Topics: Bacteremia; Child; Humans; Imipenem; Immunocompromised Host; Neoplasms | 1994 |
Imipenem resistance in Enterobacter.
Topics: Adult; Bacteremia; Cephalosporinase; Drug Resistance, Microbial; Enterobacter; Humans; Imipenem; Male; Microbial Sensitivity Tests | 1993 |
Antimicrobial activity of the new carbapenem biapenem compared to imipenem, meropenem and other broad-spectrum beta-lactam drugs.
Topics: Anti-Bacterial Agents; Bacteremia; Bacteria; Ceftazidime; Drug Resistance, Microbial; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins | 1993 |
Ochrobactrum anthropi bacteremia in a child.
Topics: Bacteremia; Ceftazidime; Child; Drug Therapy, Combination; Female; Gentamicins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vancomycin | 1993 |
Impact of different classes antimicrobial agents on plasma endotoxin activity.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Blood Pressure; Cefotaxime; Cephalosporins; Ciprofloxacin; Colony Count, Microbial; Disease Models, Animal; Endotoxins; Escherichia coli; Escherichia coli Infections; Gentamicins; Imipenem; Male; Peritoneal Diseases; Peritoneum; Rats; Rats, Wistar; Thienamycins | 1996 |
Relationship between outer membrane protein profiles and resistance to ceftazidime, imipenem, and ciprofloxacin in Pseudomonas aeruginosa isolates from bacteremic patients.
Topics: Anti-Infective Agents; Bacteremia; Bacterial Outer Membrane Proteins; Ceftazidime; Cephalosporins; Ciprofloxacin; Humans; Imipenem; Pseudomonas aeruginosa; Thienamycins | 1996 |
Increased bactericidal activity as documented by serum bactericidal titers for a triple combination of cell wall active agents against gentamicin-resistant enterococci.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecalis; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Imipenem; Penicillins; Serum Bactericidal Test; Thienamycins; Vancomycin | 1995 |
Effect of imipenem on monoclonal antibody-mediated protection against Escherichia coli O18K5.
Topics: Animals; Antibodies, Monoclonal; Bacteremia; Escherichia coli; Female; Flow Cytometry; Helicobacter; Imipenem; Mice; Mice, Inbred BALB C; Thienamycins | 1996 |
Effect of intraperitoneal antimicrobials on the concentration of bacteria, endotoxin, and tumor necrosis factor in abdominal fluid and plasma in rats.
Topics: Abdomen; Animals; Anti-Bacterial Agents; Bacteremia; Bacteria; Body Fluids; Cilastatin; Colony Count, Microbial; Endotoxins; Imipenem; Injections, Intraperitoneal; Male; Osmolar Concentration; Rats; Rats, Wistar; Survival Analysis; Taurine; Thiadiazines; Tumor Necrosis Factor-alpha | 1996 |
Bacteremia versus endotoxemia in experimental mouse leukopenia--role of antibiotic chemotherapy.
Topics: Animals; Antibodies, Monoclonal; Bacteremia; Ceftazidime; Cephalosporins; Cyclophosphamide; Endotoxemia; Escherichia coli; Escherichia coli Infections; Female; Galactosamine; Imipenem; Immunity, Innate; Interferon-gamma; Leukopenia; Mice; O Antigens; Thienamycins | 1996 |
Imipenen-resistant Ps. aeruginosa bacteraemia in cancer patients: risk factors, clinical features and outcome.
Topics: Adult; Bacteremia; Cancer Care Facilities; Drug Resistance, Microbial; Humans; Imipenem; Incidence; Neoplasms; Pseudomonas Infections; Risk Factors; Shock, Septic; Slovakia; Thienamycins | 1996 |
Increasing incidence of carbapenem-resistant Pseudomonas aeruginosa bacteraemia in a cancer centre over a seven-year period.
Topics: Bacteremia; Carbapenems; Cross Infection; Drug Resistance, Microbial; Humans; Imipenem; Incidence; Pseudomonas Infections; Retrospective Studies; Thienamycins | 1997 |
Imipenem-resistant Ps. aeruginosa bacteraemia in cancer patients: risk factors, clinical features and outcome.
Topics: Adult; Bacteremia; Drug Resistance, Microbial; Humans; Imipenem; Neoplasms; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Thienamycins | 1996 |
Antimicrobial effects of continuous versus intermittent administration of carbapenem antibiotics in an in vitro dynamic model.
Topics: Bacteremia; Carbapenems; Drug Administration Schedule; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thienamycins | 1997 |
Secular trends in bloodstream infection caused by antimicrobial-resistant bacteria in New Jersey hospitals, 1991 to 1995.
Topics: Bacteremia; Cross Infection; Data Collection; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, Private; Humans; Imipenem; Microbial Sensitivity Tests; New Jersey; Penicillin Resistance; Pneumococcal Infections; Prevalence; Species Specificity; Streptococcus pneumoniae; Vancomycin | 1997 |
[Primary peritonitis caused by Streptococcus pneumoniae].
Topics: Abdominal Pain; Adult; Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; Cilastatin; Diarrhea; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Laparotomy; Penicillins; Peritonitis; Pneumococcal Infections; Protease Inhibitors; Puerperal Infection; Thienamycins; Treatment Outcome; Vagina | 1997 |
Bacteremic pneumonia in neutropenic patients with cancer: causes, empirical antibiotic therapy, and outcome.
Topics: Aged; Bacteremia; Ceftazidime; Cephalosporins; Female; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Pneumonia, Bacterial; Thienamycins; Treatment Outcome | 1998 |
Morganella morganii early onset sepsis.
Topics: Adult; Ampicillin Resistance; Bacteremia; Cefotaxime; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Administration Schedule; Drug Combinations; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Follow-Up Studies; Gentamicins; Humans; Imipenem; Infant, Newborn; Injections, Intravenous; Male; Pregnancy; Pregnancy Complications, Infectious; Proteus; Proteus Infections; Puerperal Infection; Treatment Outcome | 1998 |
Detection of portal and systemic bacteremia in dogs with severe induced hepatic disease and multiple portosystemic shunts.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Bacteremia; Dog Diseases; Dogs; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Hypertension, Portal; Imipenem; Liver Cirrhosis, Experimental; Male; Portal System; Portography; Pseudomonas aeruginosa; Quinolones; Random Allocation; Thienamycins | 1999 |
Bacillus cereus fatal bacteremia and apparent association with nosocomial transmission in an intensive care unit.
Topics: Adenocarcinoma; Anti-Bacterial Agents; Bacillus cereus; Bacteremia; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Fatal Outcome; Female; Humans; Imipenem; Intensive Care Units; Lung Neoplasms; Microbial Sensitivity Tests; Middle Aged; Thienamycins; Vancomycin | 2000 |
Pharmacokinetic and clinical evaluation of serious infections in premature and newborn infants under therapy with imipenem/cilastatin.
Topics: Bacteremia; Cilastatin; Dose-Response Relationship, Drug; Female; Humans; Imipenem; Infant, Newborn; Infant, Premature, Diseases; Infusions, Intravenous; Intensive Care Units, Neonatal; Male; Prognosis; Protease Inhibitors; Retrospective Studies; Severity of Illness Index; Survival Rate; Thienamycins | 1999 |
Imipenem therapy for septicemic melioidosis in a child with penicillin and cephalosporin adverse reaction.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; Ceftazidime; Cephalosporins; Child; Diabetes Complications; Drug Therapy, Combination; Humans; Imipenem; Male; Melioidosis; Thienamycins | 2000 |
Epidemiology, resistance, and outcomes of Acinetobacter baumannii bacteremia treated with imipenem-cilastatin or ampicillin-sulbactam.
Topics: Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Bacteremia; Chi-Square Distribution; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Retrospective Studies; Statistics, Nonparametric; Sulbactam; Treatment Outcome | 2001 |
[Pacemaker-cable endocarditis and spondylodiscitis caused by Citrobacter koseri. Conservative treatment].
Topics: Aged; Bacteremia; Cefotaxime; Citrobacter; Discitis; Drug Therapy, Combination; Electrodes, Implanted; Endocarditis, Bacterial; Enterobacteriaceae Infections; Equipment Contamination; Humans; Imipenem; Lumbar Vertebrae; Male; Pacemaker, Artificial; Sacrum; Tobramycin | 2001 |
Case-control study of risk factors for the development of enterococcal bacteremia.
Topics: Adult; Aged; Bacteremia; Case-Control Studies; Catheters, Indwelling; Cephalosporins; Cross Infection; Enterococcus; Female; Humans; Imipenem; Incidence; Male; Middle Aged; Multivariate Analysis; Neutropenia; Prospective Studies; Risk Factors; Statistics, Nonparametric; Thienamycins | 2001 |
Comparative evaluation of penicillin, ampicillin, and imipenem MICs and susceptibility breakpoints for vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis and Enterococcus faecium.
Topics: Anti-Bacterial Agents; Bacteremia; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Penicillins; Vancomycin; Vancomycin Resistance | 2001 |
Recurrent bacteremia caused by Rhodococcus equi in a non-neutropenic patient with acute myeloid leukemia in complete remission.
Topics: Actinomycetales Infections; Adult; Amikacin; Bacteremia; Catheters, Indwelling; Ceftazidime; Cilastatin; Drug Resistance; Drug Therapy, Combination; Erythromycin; Female; Humans; Imipenem; Immunocompromised Host; Leukemia, Myelomonocytic, Acute; Neutropenia; Pneumonia, Bacterial; Recurrence; Rhodococcus equi; Vancomycin | 2002 |
Enterococcal superinfection in paediatric oncology patients treated with imipenem.
Topics: Bacteremia; Child; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Imipenem; Neoplasms; Superinfection | 1992 |
Umbilical catheter-related resistant Klebsiella septicaemia in a pre-term infant successfully treated with imipenem via the catheter.
Topics: Bacteremia; Catheterization; Drug Resistance, Microbial; Humans; Imipenem; Infant, Newborn; Infant, Premature, Diseases; Klebsiella Infections; Male; Umbilicus | 1992 |
Imipenem resistance associated with the loss of a 40 kDa outer membrane protein in Enterobacter aerogenes.
Topics: Bacteremia; Bacterial Outer Membrane Proteins; beta-Lactamases; Drug Resistance, Microbial; Hydrolysis; Imipenem; Isoelectric Focusing; Klebsiella pneumoniae; Microbial Sensitivity Tests | 1991 |